Global Emerging Infectious Disease Market Growth (Status and Outlook) 2026-2032

August 2026 | 103 pages | ID: G79EF6117EB2EN
LP Information

Abstracts

The global Emerging Infectious Disease market size is predicted to grow from US$ 22320 million in 2025 to US$ 33570 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032.

Emerging infectious diseases can be defined as infectious diseases that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range, or that are caused by one of the NIAID Category A, B, or C priority pathogens.

The global emerging infectious disease market refers to the market for diagnostics, treatments, and preventive measures for newly discovered or re-emerging infectious diseases. Emerging infectious diseases are those that have recently appeared in a population or have existed but are rapidly increasing in incidence or geographic range. These diseases pose a significant public health threat and require innovative approaches for detection, management, and control.

Here are some key factors influencing the growth of the global emerging infectious disease market:

Outbreaks and epidemics: The occurrence of outbreaks and epidemics of emerging infectious diseases, such as Ebola, Zika virus, and COVID-19, has created a heightened global awareness of the need for robust diagnostic tools, therapeutics, and preventive measures. These outbreaks drive the demand for rapid and accurate diagnostics to identify the causative agents, along with effective treatments and preventive strategies to control the spread of the diseases.

Technological advancements: Advances in diagnostic technologies, including nucleic acid amplification techniques, immunoassays, and point-of-care diagnostics, have significantly improved the speed and accuracy of diagnosing emerging infectious diseases. Additionally, the development of new antiviral drugs, vaccines, and other therapeutics has expanded treatment options for these diseases. The integration of technologies such as artificial intelligence, genomics, and big data analytics further enhances the capabilities of the healthcare system in managing emerging infectious diseases.

Government initiatives and funding: Governments and international organizations have recognized the need to invest in research and development, surveillance systems, and infrastructure to effectively respond to emerging infectious diseases. Increased funding and initiatives aimed at strengthening healthcare systems, surveillance networks, and research collaborations drive innovations in diagnostics, therapeutics, and preventive measures.

Global travel and urbanization: Increased global travel and urbanization contribute to the spread and emergence of infectious diseases. The movement of people across borders allows infections to spread rapidly, making it crucial to have effective measures in place for detection, containment, and treatment. This drives the demand for improved diagnostics, therapeutics, and public health strategies targeting emerging infectious diseases.

Antimicrobial resistance: The rise of antimicrobial resistance poses a significant challenge in the management of emerging infectious diseases. The limited effectiveness of existing antibiotics and antiviral drugs necessitates the development of new treatment options, including novel antibiotics, combination therapies, and innovative strategies that target the resistance mechanisms of pathogens.

The global emerging infectious disease market can be segmented based on disease type, diagnostic methods, treatment modalities, and geography. Disease types may include viral, bacterial, parasitic, and others. Diagnostic methods can include molecular diagnostics, immunoassays, and rapid diagnostic tests. Treatment modalities may include antiviral drugs, antibiotics, vaccines, and supportive care.

Geographically, the market can be divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The prevalence of different emerging infectious diseases, healthcare infrastructure, and government initiatives may vary across these regions.

In summary, the global emerging infectious disease market is driven by outbreaks and epidemics, technological advancements, government initiatives, global travel, and antimicrobial resistance. Key players in the market are focused on developing innovative solutions for diagnostics, treatments, and preventive measures. The market is expected to witness significant growth as the need for effective management of emerging infectious diseases continues to rise globally.

LPI (LP Information)' newest research report, the “Emerging Infectious Disease Industry Forecast” looks at past sales and reviews total world Emerging Infectious Disease sales in 2025, providing a comprehensive analysis by region and market sector of projected Emerging Infectious Disease sales for 2026 through 2032. With Emerging Infectious Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Emerging Infectious Disease industry.

This Insight Report provides a comprehensive analysis of the global Emerging Infectious Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Emerging Infectious Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Emerging Infectious Disease market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Emerging Infectious Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Emerging Infectious Disease.

This report presents a comprehensive overview, market shares, and growth opportunities of Emerging Infectious Disease market by product type, application, key players and key regions and countries.

Segmentation by Type:

• AIDS
• Ebola
• SARS
• Avian Flu
• Chikungunya
• Zika
• Others

Segmentation by Application:

• Clinical Laboratories
• Diagnostic Centers
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• BD
• Abbott
• Roche Diagnostics
• Merck & Co., Inc.
• GlaxoSmithKline plc
• BioMerieux
• Danaher
• Orasure
• Qiagen
• Quidel
• Sysmex
• Gen-Probe
• Cepheid
• Hologic

Contents

1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
    2.1.1 Global Emerging Infectious Disease Market Size (2021-2032)
    2.1.2 Emerging Infectious Disease Market Size CAGR by Region (2021 VS 2025 VS 2032)
    2.1.3 World Current & Future Analysis for Emerging Infectious Disease by Country/Region (2021, 2025 & 2032)
  2.2 Emerging Infectious Disease Segment by Type
    2.2.1 AIDS
    2.2.2 Ebola
    2.2.3 SARS
    2.2.4 Avian Flu
    2.2.5 Chikungunya
    2.2.6 Zika
    2.2.7 Others
    2.2.8 Emerging Infectious Disease Market Size by Type
      2.2.8.1 Emerging Infectious Disease Market Size CAGR by Type (2021 VS 2025 VS 2032)
      2.2.8.2 Global Emerging Infectious Disease Market Size Market Share by Type (2021-2026)
  2.3 Emerging Infectious Disease Segment by Application
    2.3.1 Clinical Laboratories
    2.3.2 Diagnostic Centers
    2.3.3 Others
    2.3.4 Emerging Infectious Disease Market Size by Application
      2.3.4.1 Emerging Infectious Disease Market Size CAGR by Application (2021 VS 2025 VS 2032)
      2.3.4.2 Global Emerging Infectious Disease Market Size Market Share by Application (2021-2026)

3 EMERGING INFECTIOUS DISEASE MARKET SIZE BY PLAYER

  3.1 Emerging Infectious Disease Market Size Market Share by Player
    3.1.1 Global Emerging Infectious Disease Revenue by Player (2021-2026)
    3.1.2 Global Emerging Infectious Disease Revenue Market Share by Player (2021-2026)
  3.2 Global Emerging Infectious Disease Key Players Head office and Products Offered
  3.3 Market Concentration Rate Analysis
    3.3.1 Competition Landscape Analysis
    3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.4 New Products and Potential Entrants
  3.5 Mergers & Acquisitions, Expansion

4 EMERGING INFECTIOUS DISEASE BY REGION

  4.1 Emerging Infectious Disease Market Size by Region (2021-2026)
  4.2 Global Emerging Infectious Disease Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Emerging Infectious Disease Market Size Growth (2021-2026)
  4.4 APAC Emerging Infectious Disease Market Size Growth (2021-2026)
  4.5 Europe Emerging Infectious Disease Market Size Growth (2021-2026)
  4.6 Middle East & Africa Emerging Infectious Disease Market Size Growth (2021-2026)

5 AMERICAS

  5.1 Americas Emerging Infectious Disease Market Size by Country (2021-2026)
  5.2 Americas Emerging Infectious Disease Market Size by Type (2021-2026)
  5.3 Americas Emerging Infectious Disease Market Size by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Emerging Infectious Disease Market Size by Region (2021-2026)
  6.2 APAC Emerging Infectious Disease Market Size by Type (2021-2026)
  6.3 APAC Emerging Infectious Disease Market Size by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia

7 EUROPE

  7.1 Europe Emerging Infectious Disease Market Size by Country (2021-2026)
  7.2 Europe Emerging Infectious Disease Market Size by Type (2021-2026)
  7.3 Europe Emerging Infectious Disease Market Size by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Emerging Infectious Disease by Region (2021-2026)
  8.2 Middle East & Africa Emerging Infectious Disease Market Size by Type (2021-2026)
  8.3 Middle East & Africa Emerging Infectious Disease Market Size by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 GLOBAL EMERGING INFECTIOUS DISEASE MARKET FORECAST

  10.1 Global Emerging Infectious Disease Forecast by Region (2027-2032)
    10.1.1 Global Emerging Infectious Disease Forecast by Region (2027-2032)
    10.1.2 Americas Emerging Infectious Disease Forecast
    10.1.3 APAC Emerging Infectious Disease Forecast
    10.1.4 Europe Emerging Infectious Disease Forecast
    10.1.5 Middle East & Africa Emerging Infectious Disease Forecast
  10.2 Americas Emerging Infectious Disease Forecast by Country (2027-2032)
    10.2.1 United States Market Emerging Infectious Disease Forecast
    10.2.2 Canada Market Emerging Infectious Disease Forecast
    10.2.3 Mexico Market Emerging Infectious Disease Forecast
    10.2.4 Brazil Market Emerging Infectious Disease Forecast
  10.3 APAC Emerging Infectious Disease Forecast by Region (2027-2032)
    10.3.1 China Emerging Infectious Disease Market Forecast
    10.3.2 Japan Market Emerging Infectious Disease Forecast
    10.3.3 Korea Market Emerging Infectious Disease Forecast
    10.3.4 Southeast Asia Market Emerging Infectious Disease Forecast
    10.3.5 India Market Emerging Infectious Disease Forecast
    10.3.6 Australia Market Emerging Infectious Disease Forecast
  10.4 Europe Emerging Infectious Disease Forecast by Country (2027-2032)
    10.4.1 Germany Market Emerging Infectious Disease Forecast
    10.4.2 France Market Emerging Infectious Disease Forecast
    10.4.3 UK Market Emerging Infectious Disease Forecast
    10.4.4 Italy Market Emerging Infectious Disease Forecast
    10.4.5 Russia Market Emerging Infectious Disease Forecast
  10.5 Middle East & Africa Emerging Infectious Disease Forecast by Region (2027-2032)
    10.5.1 Egypt Market Emerging Infectious Disease Forecast
    10.5.2 South Africa Market Emerging Infectious Disease Forecast
    10.5.3 Israel Market Emerging Infectious Disease Forecast
    10.5.4 Turkey Market Emerging Infectious Disease Forecast
  10.6 Global Emerging Infectious Disease Forecast by Type (2027-2032)
  10.7 Global Emerging Infectious Disease Forecast by Application (2027-2032)
    10.7.1 GCC Countries Market Emerging Infectious Disease Forecast

11 KEY PLAYERS ANALYSIS

  11.1 BD
    11.1.1 BD Company Information
    11.1.2 BD Emerging Infectious Disease Product Offered
    11.1.3 BD Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
    11.1.4 BD Main Business Overview
    11.1.5 BD Latest Developments
  11.2 Abbott
    11.2.1 Abbott Company Information
    11.2.2 Abbott Emerging Infectious Disease Product Offered
    11.2.3 Abbott Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
    11.2.4 Abbott Main Business Overview
    11.2.5 Abbott Latest Developments
  11.3 Roche Diagnostics
    11.3.1 Roche Diagnostics Company Information
    11.3.2 Roche Diagnostics Emerging Infectious Disease Product Offered
    11.3.3 Roche Diagnostics Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
    11.3.4 Roche Diagnostics Main Business Overview
    11.3.5 Roche Diagnostics Latest Developments
  11.4 Merck & Co., Inc.
    11.4.1 Merck & Co., Inc. Company Information
    11.4.2 Merck & Co., Inc. Emerging Infectious Disease Product Offered
    11.4.3 Merck & Co., Inc. Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
    11.4.4 Merck & Co., Inc. Main Business Overview
    11.4.5 Merck & Co., Inc. Latest Developments
  11.5 GlaxoSmithKline plc
    11.5.1 GlaxoSmithKline plc Company Information
    11.5.2 GlaxoSmithKline plc Emerging Infectious Disease Product Offered
    11.5.3 GlaxoSmithKline plc Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
    11.5.4 GlaxoSmithKline plc Main Business Overview
    11.5.5 GlaxoSmithKline plc Latest Developments
  11.6 BioMerieux
    11.6.1 BioMerieux Company Information
    11.6.2 BioMerieux Emerging Infectious Disease Product Offered
    11.6.3 BioMerieux Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
    11.6.4 BioMerieux Main Business Overview
    11.6.5 BioMerieux Latest Developments
  11.7 Danaher
    11.7.1 Danaher Company Information
    11.7.2 Danaher Emerging Infectious Disease Product Offered
    11.7.3 Danaher Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
    11.7.4 Danaher Main Business Overview
    11.7.5 Danaher Latest Developments
  11.8 Orasure
    11.8.1 Orasure Company Information
    11.8.2 Orasure Emerging Infectious Disease Product Offered
    11.8.3 Orasure Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
    11.8.4 Orasure Main Business Overview
    11.8.5 Orasure Latest Developments
  11.9 Qiagen
    11.9.1 Qiagen Company Information
    11.9.2 Qiagen Emerging Infectious Disease Product Offered
    11.9.3 Qiagen Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
    11.9.4 Qiagen Main Business Overview
    11.9.5 Qiagen Latest Developments
  11.10 Quidel
    11.10.1 Quidel Company Information
    11.10.2 Quidel Emerging Infectious Disease Product Offered
    11.10.3 Quidel Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
    11.10.4 Quidel Main Business Overview
    11.10.5 Quidel Latest Developments
  11.11 Sysmex
    11.11.1 Sysmex Company Information
    11.11.2 Sysmex Emerging Infectious Disease Product Offered
    11.11.3 Sysmex Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
    11.11.4 Sysmex Main Business Overview
    11.11.5 Sysmex Latest Developments
  11.12 Gen-Probe
    11.12.1 Gen-Probe Company Information
    11.12.2 Gen-Probe Emerging Infectious Disease Product Offered
    11.12.3 Gen-Probe Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
    11.12.4 Gen-Probe Main Business Overview
    11.12.5 Gen-Probe Latest Developments
  11.13 Cepheid
    11.13.1 Cepheid Company Information
    11.13.2 Cepheid Emerging Infectious Disease Product Offered
    11.13.3 Cepheid Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
    11.13.4 Cepheid Main Business Overview
    11.13.5 Cepheid Latest Developments
  11.14 Hologic
    11.14.1 Hologic Company Information
    11.14.2 Hologic Emerging Infectious Disease Product Offered
    11.14.3 Hologic Emerging Infectious Disease Revenue, Gross Margin and Market Share (2021-2026)
    11.14.4 Hologic Main Business Overview
    11.14.5 Hologic Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Emerging Infectious Disease Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Emerging Infectious Disease Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of AIDS
Table 4. Major Players of Ebola
Table 5. Major Players of SARS
Table 6. Major Players of Avian Flu
Table 7. Major Players of Chikungunya
Table 8. Major Players of Zika
Table 9. Major Players of Others
Table 10. Emerging Infectious Disease Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Emerging Infectious Disease Market Size by Type (2021-2026) & ($ millions)
Table 12. Global Emerging Infectious Disease Market Size Market Share by Type (2021-2026)
Table 13. Emerging Infectious Disease Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Emerging Infectious Disease Market Size by Application (2021-2026) & ($ millions)
Table 15. Global Emerging Infectious Disease Market Size Market Share by Application (2021-2026)
Table 16. Global Emerging Infectious Disease Revenue by Player (2021-2026) & ($ millions)
Table 17. Global Emerging Infectious Disease Revenue Market Share by Player (2021-2026)
Table 18. Emerging Infectious Disease Key Players Head office and Products Offered
Table 19. Emerging Infectious Disease Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Emerging Infectious Disease Market Size by Region (2021-2026) & ($ millions)
Table 23. Global Emerging Infectious Disease Market Size Market Share by Region (2021-2026)
Table 24. Global Emerging Infectious Disease Revenue by Country/Region (2021-2026) & ($ millions)
Table 25. Global Emerging Infectious Disease Revenue Market Share by Country/Region (2021-2026)
Table 26. Americas Emerging Infectious Disease Market Size by Country (2021-2026) & ($ millions)
Table 27. Americas Emerging Infectious Disease Market Size Market Share by Country (2021-2026)
Table 28. Americas Emerging Infectious Disease Market Size by Type (2021-2026) & ($ millions)
Table 29. Americas Emerging Infectious Disease Market Size Market Share by Type (2021-2026)
Table 30. Americas Emerging Infectious Disease Market Size by Application (2021-2026) & ($ millions)
Table 31. Americas Emerging Infectious Disease Market Size Market Share by Application (2021-2026)
Table 32. APAC Emerging Infectious Disease Market Size by Region (2021-2026) & ($ millions)
Table 33. APAC Emerging Infectious Disease Market Size Market Share by Region (2021-2026)
Table 34. APAC Emerging Infectious Disease Market Size by Type (2021-2026) & ($ millions)
Table 35. APAC Emerging Infectious Disease Market Size by Application (2021-2026) & ($ millions)
Table 36. Europe Emerging Infectious Disease Market Size by Country (2021-2026) & ($ millions)
Table 37. Europe Emerging Infectious Disease Market Size Market Share by Country (2021-2026)
Table 38. Europe Emerging Infectious Disease Market Size by Type (2021-2026) & ($ millions)
Table 39. Europe Emerging Infectious Disease Market Size by Application (2021-2026) & ($ millions)
Table 40. Middle East & Africa Emerging Infectious Disease Market Size by Region (2021-2026) & ($ millions)
Table 41. Middle East & Africa Emerging Infectious Disease Market Size by Type (2021-2026) & ($ millions)
Table 42. Middle East & Africa Emerging Infectious Disease Market Size by Application (2021-2026) & ($ millions)
Table 43. Key Market Drivers & Growth Opportunities of Emerging Infectious Disease
Table 44. Key Market Challenges & Risks of Emerging Infectious Disease
Table 45. Key Industry Trends of Emerging Infectious Disease
Table 46. Global Emerging Infectious Disease Market Size Forecast by Region (2027-2032) & ($ millions)
Table 47. Global Emerging Infectious Disease Market Size Market Share Forecast by Region (2027-2032)
Table 48. Global Emerging Infectious Disease Market Size Forecast by Type (2027-2032) & ($ millions)
Table 49. Global Emerging Infectious Disease Market Size Forecast by Application (2027-2032) & ($ millions)
Table 50. BD Details, Company Type, Emerging Infectious Disease Area Served and Its Competitors
Table 51. BD Emerging Infectious Disease Product Offered
Table 52. BD Emerging Infectious Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. BD Main Business
Table 54. BD Latest Developments
Table 55. Abbott Details, Company Type, Emerging Infectious Disease Area Served and Its Competitors
Table 56. Abbott Emerging Infectious Disease Product Offered
Table 57. Abbott Emerging Infectious Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Abbott Main Business
Table 59. Abbott Latest Developments
Table 60. Roche Diagnostics Details, Company Type, Emerging Infectious Disease Area Served and Its Competitors
Table 61. Roche Diagnostics Emerging Infectious Disease Product Offered
Table 62. Roche Diagnostics Emerging Infectious Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Roche Diagnostics Main Business
Table 64. Roche Diagnostics Latest Developments
Table 65. Merck & Co., Inc. Details, Company Type, Emerging Infectious Disease Area Served and Its Competitors
Table 66. Merck & Co., Inc. Emerging Infectious Disease Product Offered
Table 67. Merck & Co., Inc. Emerging Infectious Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Merck & Co., Inc. Main Business
Table 69. Merck & Co., Inc. Latest Developments
Table 70. GlaxoSmithKline plc Details, Company Type, Emerging Infectious Disease Area Served and Its Competitors
Table 71. GlaxoSmithKline plc Emerging Infectious Disease Product Offered
Table 72. GlaxoSmithKline plc Emerging Infectious Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. GlaxoSmithKline plc Main Business
Table 74. GlaxoSmithKline plc Latest Developments
Table 75. BioMerieux Details, Company Type, Emerging Infectious Disease Area Served and Its Competitors
Table 76. BioMerieux Emerging Infectious Disease Product Offered
Table 77. BioMerieux Emerging Infectious Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. BioMerieux Main Business
Table 79. BioMerieux Latest Developments
Table 80. Danaher Details, Company Type, Emerging Infectious Disease Area Served and Its Competitors
Table 81. Danaher Emerging Infectious Disease Product Offered
Table 82. Danaher Emerging Infectious Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Danaher Main Business
Table 84. Danaher Latest Developments
Table 85. Orasure Details, Company Type, Emerging Infectious Disease Area Served and Its Competitors
Table 86. Orasure Emerging Infectious Disease Product Offered
Table 87. Orasure Emerging Infectious Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Orasure Main Business
Table 89. Orasure Latest Developments
Table 90. Qiagen Details, Company Type, Emerging Infectious Disease Area Served and Its Competitors
Table 91. Qiagen Emerging Infectious Disease Product Offered
Table 92. Qiagen Emerging Infectious Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Qiagen Main Business
Table 94. Qiagen Latest Developments
Table 95. Quidel Details, Company Type, Emerging Infectious Disease Area Served and Its Competitors
Table 96. Quidel Emerging Infectious Disease Product Offered
Table 97. Quidel Emerging Infectious Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Quidel Main Business
Table 99. Quidel Latest Developments
Table 100. Sysmex Details, Company Type, Emerging Infectious Disease Area Served and Its Competitors
Table 101. Sysmex Emerging Infectious Disease Product Offered
Table 102. Sysmex Emerging Infectious Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Sysmex Main Business
Table 104. Sysmex Latest Developments
Table 105. Gen-Probe Details, Company Type, Emerging Infectious Disease Area Served and Its Competitors
Table 106. Gen-Probe Emerging Infectious Disease Product Offered
Table 107. Gen-Probe Emerging Infectious Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Gen-Probe Main Business
Table 109. Gen-Probe Latest Developments
Table 110. Cepheid Details, Company Type, Emerging Infectious Disease Area Served and Its Competitors
Table 111. Cepheid Emerging Infectious Disease Product Offered
Table 112. Cepheid Emerging Infectious Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Cepheid Main Business
Table 114. Cepheid Latest Developments
Table 115. Hologic Details, Company Type, Emerging Infectious Disease Area Served and Its Competitors
Table 116. Hologic Emerging Infectious Disease Product Offered
Table 117. Hologic Emerging Infectious Disease Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Hologic Main Business
Table 119. Hologic Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Emerging Infectious Disease Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Emerging Infectious Disease Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Emerging Infectious Disease Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Emerging Infectious Disease Sales Market Share by Country/Region (2025)
Figure 8. Emerging Infectious Disease Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Emerging Infectious Disease Market Size Market Share by Type in 2025
Figure 10. Emerging Infectious Disease in Clinical Laboratories
Figure 11. Global Emerging Infectious Disease Market: Clinical Laboratories (2021-2026) & ($ millions)
Figure 12. Emerging Infectious Disease in Diagnostic Centers
Figure 13. Global Emerging Infectious Disease Market: Diagnostic Centers (2021-2026) & ($ millions)
Figure 14. Emerging Infectious Disease in Others
Figure 15. Global Emerging Infectious Disease Market: Others (2021-2026) & ($ millions)
Figure 16. Global Emerging Infectious Disease Market Size Market Share by Application in 2025
Figure 17. Global Emerging Infectious Disease Revenue Market Share by Player in 2025
Figure 18. Global Emerging Infectious Disease Market Size Market Share by Region (2021-2026)
Figure 19. Americas Emerging Infectious Disease Market Size 2021-2026 ($ millions)
Figure 20. APAC Emerging Infectious Disease Market Size 2021-2026 ($ millions)
Figure 21. Europe Emerging Infectious Disease Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Emerging Infectious Disease Market Size 2021-2026 ($ millions)
Figure 23. Americas Emerging Infectious Disease Value Market Share by Country in 2025
Figure 24. United States Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Emerging Infectious Disease Market Size Market Share by Region in 2025
Figure 29. APAC Emerging Infectious Disease Market Size Market Share by Type (2021-2026)
Figure 30. APAC Emerging Infectious Disease Market Size Market Share by Application (2021-2026)
Figure 31. China Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 35. India Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Emerging Infectious Disease Market Size Market Share by Country in 2025
Figure 38. Europe Emerging Infectious Disease Market Size Market Share by Type (2021-2026)
Figure 39. Europe Emerging Infectious Disease Market Size Market Share by Application (2021-2026)
Figure 40. Germany Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 41. France Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Emerging Infectious Disease Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Emerging Infectious Disease Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Emerging Infectious Disease Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Emerging Infectious Disease Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 54. APAC Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 55. Europe Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 57. United States Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 58. Canada Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 59. Mexico Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 60. Brazil Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 61. China Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 62. Japan Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 63. Korea Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 65. India Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 66. Australia Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 67. Germany Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 68. France Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 69. UK Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 70. Italy Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 71. Russia Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 72. Egypt Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 73. South Africa Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 74. Israel Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 75. Turkey Emerging Infectious Disease Market Size 2027-2032 ($ millions)
Figure 76. Global Emerging Infectious Disease Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Emerging Infectious Disease Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Emerging Infectious Disease Market Size 2027-2032 ($ millions)